In another clinical trial in HLA-A2 positive patients with high-risk castration-sensitive prostate cancer who were vaccinated with a PSA peptide, there was a significant inverse correlation between changes in serum PSA levels and differences in average tetramer measurements at baseline and at week 26 (p = 0.02) [20]. Here, KLK3 is linked to prostate carcinoma.